Select for export The Potential of Psilocybin Administration in Terminal Cancer Patients Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/01.cot.0000574916.46844.cf Copy citation Copy BibTeX Oncology Times 2019-06-27 Richard Simoneaux OpenAlex Published psilocybinpsilocin DepressionAnxietyAddiction Clinical Trial More
Select for export Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1017/neu.2019.15 PubMed 31106729 Copy citation Copy BibTeX Acta Neuropsychiatrica 2019-05-19 Oskar Hougaard Jefsen, Kristoffer Højgaard, Sofie Laage Christiansen, Betina Elfving, David Nutt, Gregers Wegener OpenAlex Published psilocybinpsilocin DepressionPharmacologyReceptor Pharmacology Animal Study More
Select for export Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1037/pha0000253 PubMed 30628811 Copy citation Copy BibTeX Experimental and Clinical Psychopharmacology 2019-01-09 Farhana Sakloth, Elizabeth Leggett, Megan J. Moerke, E. Andrew Townsend, Matthew L. Banks, S. Stevens Negus OpenAlex Published psilocybin DepressionAddictionPharmacology Animal Study More
Select for export The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-018-5042-1 PubMed 30288594 Copy citation Copy BibTeX Unknown journal 2018-10-04 Jalal B. Europe PMC Published psilocybin AnxietyPharmacologyMechanism of Action Other More
Select for export Serotonin, psychedelics and psychiatry Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/wps.20555 PubMed 30192100 Copy citation Copy BibTeX World Psychiatry 2018-09-06 Robin Carhart-Harris OpenAlex Published psilocybin DepressionAnxietyAddiction Randomized Controlled Trial More
Select for export Psychedelics as anti-inflammatory agents. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/09540261.2018.1481827 PubMed 30102081 Copy citation Copy BibTeX International Review of Psychiatry 2018-08-12 Flanagan TW, Nichols CD. Europe PMC Published psilocybin DepressionAnxietyAddiction Review Article More
Select for export Alteration of Depressive-like Behaviors by Psilocybe cubensis Alkaloid Extract in Mice: the Role of Glutamate Pathway Abstract available at the source but not redistributed here. Read at source. Details DOI 10.22127/rjp.2018.58486 Copy citation Copy BibTeX DOAJ (DOAJ: Directory of Open Access Journals) 2018-02-28 Elaheh Mahmoudi, Mehrdad Faizi, Reza Hajiaghaee, Ali Razmi OpenAlex Published psilocybin DepressionAnxietyPharmacology Animal Study More
Select for export Horizontal gene cluster transfer increased hallucinogenic mushroom diversity. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/evl3.42 PubMed 30283667 Copy citation Copy BibTeX Evolution Letters 2018-02-26 Reynolds HT, Vijayakumar V, Gluck-Thaler E, Korotkin HB, Matheny PB, Slot JC. Europe PMC Published psilocybinpsilocin Receptor PharmacologyConsciousnessDrug Interactions Other More
Select for export If you give a mouse a mushroom: Behavioral effects of hallucinogens in mice Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX eScholarship (California Digital Library) 2017-12-31 Landon M. Klein OpenAlex Published psilocybinpsilocin PharmacologyMechanism of ActionReceptor Pharmacology Animal Study More
Select for export Therapeutic Applications of Classic Hallucinogens. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/7854_2016_464 PubMed 28512684 Copy citation Copy BibTeX Unknown journal 2017-12-31 Bogenschutz MP, Ross S. Europe PMC Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/7854_2017_478 PubMed 28677096 Copy citation Copy BibTeX Unknown journal 2017-12-31 López-Giménez JF, González-Maeso J. Europe PMC Published psilocybin Mechanism of ActionReceptor PharmacologyConsciousness Review Article More
Select for export Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41598-017-13282-7 PubMed 29030624 Copy citation Copy BibTeX Scientific Reports 2017-10-12 Carhart-Harris RL, Roseman L, Bolstridge M, Demetriou L, Pannekoek JN, Wall MB Europe PMC Published psilocybin DepressionBrain ImagingMechanism of Action Other More
Select for export Horizontal gene cluster transfer increased hallucinogenic mushroom diversity Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/176347 Copy citation Copy BibTeX bioRxiv 2017-08-14 Reynolds HT, Vijayakumar V, Gluck-Thaler E, Korotkin HB, Matheny PB, Slot JC. bioRxiv PREPRINT (not peer reviewed) psilocybinpsilocin Receptor PharmacologyConsciousnessDrug Interactions Other More
Select for export Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuroimage.2017.07.020 PubMed 28711736 Copy citation Copy BibTeX NeuroImage 2017-07-11 Lewis CR, Preller KH, Kraehenmann R, Michels L, Staempfli P, Vollenweider FX. Europe PMC Published psilocybin Brain ImagingPharmacologyReceptor Pharmacology Other More
Select for export Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/2045125316689030 PubMed 28540034 Copy citation Copy BibTeX Unknown journal 2017-02-22 Dos Santos RG, Bouso JC, Hallak JEC. Europe PMC Published psilocybin DepressionMechanism of ActionReceptor Pharmacology Systematic Review More
Select for export Long-term follow-up of psilocybin-facilitated smoking cessation. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3109/00952990.2016.1170135 PubMed 27441452 Copy citation Copy BibTeX The American Journal of Drug and Alcohol Abuse 2016-07-20 Johnson MW, Garcia-Romeu A, Griffiths RR. Europe PMC Published psilocybin AddictionReceptor PharmacologySpirituality Other More
Select for export Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyw016 PubMed 26874330 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2016-07-04 Maqueda AE, Valle M, Addy PH, Antonijoan RM, Puntes M, Coimbra J Europe PMC Published psilocybin AddictionMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s2215-0366(16)30065-7 PubMed 27210031 Copy citation Copy BibTeX The Lancet Psychiatry 2016-05-16 Carhart-Harris RL, Bolstridge M, Rucker J, Day CM, Erritzoe D, Kaelen M Europe PMC Published psilocybin DepressionAnxietyAddiction Other More
Select for export Effects of serotonin 2A/1A receptor stimulation on social exclusion processing. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1073/pnas.1524187113 PubMed 27091970 Copy citation Copy BibTeX Proceedings of the National Academy of Sciences 2016-04-17 Preller KH, Pokorny T, Hock A, Kraehenmann R, Stämpfli P, Seifritz E Europe PMC Published psilocybin Chronic PainBrain ImagingReceptor Pharmacology Clinical Trial More
Select for export Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.euroneuro.2016.01.005 PubMed 26875114 Copy citation Copy BibTeX European Neuropsychopharmacology 2016-01-21 Pokorny T, Preller KH, Kraehenmann R, Vollenweider FX. Europe PMC Published psilocybin Receptor PharmacologyConsciousnessHealthy Volunteers Other More